Table 3:
Primary outcomes, screening rate and positivity rate, by group.
| Group (N) | Screened Overall, N (%) | Screened Positive Overall, N (%) | Screened via ATTAIN, N (%) | Screened Positive via ATTAIN, N (%) | Screened via Usual Care, N (%) | Screened Positive via Usual Care, N (%) |
|---|---|---|---|---|---|---|
| Total | ||||||
| Intervention (2249) | 1516 (67%) | 117 (7.7%) | 1057 (47%) | 101 (10%) | 909 (40%) | 18 (2%) |
| Control (2130) | 822 (39%) | 22 (2.6%) | n/a | n/a | 815 (38%) | 22 (2.6%) |
| p value | < .001 | |||||
| Group 1 | ||||||
| Intervention (737) | 560 (76%) | 53 (10%) | 417 (57%) | 44 (11%) | 324 (44%) | 9 (3%) |
| Control (657) | 240 (37%) | 8 (3%) | n/a | n/a | 235 (36%) | 8 (3%) |
| Group 2 a (pre-op) | ||||||
| Intervention (325) | 250 (77%) | 31 (12%) | 200 (62%) | 30 (18%) | 138 (42%) | 2 (1.5%) |
| Control (33) | 12 (36%) | 1 (8%) | n/a | n/a | 12 (36%) | 1 (8%) |
| Group 2b (post-op) | ||||||
| Intervention (420) | 251 (60%) | 13(5.2%) | 159 (38%) | 10 (6.8%) | 159 (38%) | 3 (2%) |
| Control (324) | 119 (37%) | 4 (3.3%) | n/a | n/a | 118 (37%) | 4 (3.3%) |
| Group 3 | ||||||
| Intervention (767) | 455 (60%) | 20 (4.4%) | 281 (37%) | 17 (6.0%) | 288 (38%) | 4 (1.4%) |
| Control (1116) | 451 (40%) | 9 (2%) | n/a | n/a | 451 (40%) | 9 (2%) |